Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Med Suisse ; 10(414): 153-7, 2014 Jan 22.
Article in French | MEDLINE | ID: mdl-24624731

ABSTRACT

This article provides an overview of 10 important articles published in year 2013 in the field of ambulatory general internal medicine. The newest guidelines about glaucoma screening are detailed. In the midst of the lung cancer screening controversy, an article summarizes new guidelines for the management of solitary pulmonary nodules. Cohort studies are detailed, which have shown association between high calcium intake and cardiovascular mortality, grade 2 or 3 obesity and mortality, aspirin use and lower melanoma incidence, and a reduction of the prevalence of dementia in last 20 years. Finally, 2 publications clarify the optimal length of corticoid treatment for COPD exacerbations and the most appropriate treatment regimen for Helicobacter Pylori eradication.


Subject(s)
Ambulatory Care/trends , General Practice/trends , Internal Medicine/trends , Humans , Periodicals as Topic , Practice Guidelines as Topic
2.
Rev Med Suisse ; 8(335): 718-22, 724-5, 2012 Apr 04.
Article in French | MEDLINE | ID: mdl-22545492

ABSTRACT

Scabies is a parasitic infection known all over the world and particularly in a low socioeconomic context and in institutions. The transmission is mainly direct from skin-to-skin. An increase of cases has been observed in Geneva since October 2011. To confirm the diagnosis, a precise clinical and microbiological examination is required and highly recommended before starting a treatment. Scabies management includes treatment of the patient and his close contacts with antiparasitic drugs as well as thorough cleaning of clothes and bed linen. When available, oral ivermectine is the treatment of choice, topical permethrine is prescribed when ivermectine cannot be used or in association with it in severe presentations. In Switzerland, ivermectine is not readily available, it is expensive and not reimbursed by insurances.


Subject(s)
Scabies/diagnosis , Scabies/drug therapy , Animals , Antiparasitic Agents/therapeutic use , Humans , Ivermectin/therapeutic use , Permethrin/therapeutic use , Scabies/epidemiology , Scabies/transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...